Diabetes Technol Ther 2012 Mar 6;14(3):225-31. Epub 2011 Dec 6.
Medtronic Diabetes, R&D, Northridge, California 91325, USA.
Objective: This study investigates the accuracy of a newly developed, next-generation subcutaneous glucose sensor, evaluated for 6-day use.
Research Design And Methods: Seventy-nine subjects (53 men, 26 women) with type 1 diabetes and 18 subjects (14 men, four women) with type 2 diabetes completed a three-center, prospective, sensor accuracy study. The mean age for the group was 42. Read More